Vyakarnam A, Eyeson J, Teo I, Zuckerman M, Babaahmady K, Schuitemaker H, Shaunak S, Rostron T, Rowland-Jones S, Simmons G, Clapham P
Department of Immunology, GKT School of Medicine and Dentistry, The Rayne Institute, London, UK.
AIDS. 2001 Sep 7;15(13):1613-26. doi: 10.1097/00002030-200109070-00003.
HIV-1 strains R5 and X4 can infect CD4 memory T cells in vivo. Anti-CD3/28 stimulation induces beta-chemokines and CCR5 down-regulation and renders these cells resistant to R5 HIV-1 infection. Here we describe an additional cellular mechanism that blocks productive R5 HIV-1 infection of CD4 memory T cells.
Blood-derived CD4 memory T cells and CD4 T-cell clones were infected with primary R5 and X4 HIV-1 strains. Virus replication was correlated with CCR5 expression and beta-chemokine production. Virus entry and infectivity were measured by PCR for early and late products of HIV reverse transcription respectively.
R5 strains were up to 1000-fold less infectious than X4 viruses for CD4 memory T cells. This resistance was independent of CCR5 levels and of the Delta-32 mutation and the CCR2-V64I/CCR5-59653T linked mutations. Blocking endogenous beta-chemokines relieved minimally this restriction. At the single cell level, CD4 memory cells were either permissive or non-permissive for R5 HIV-1 infection. R5 HIV titre was up to 10-fold lower than X4 virus titre even in a permissive clone. However, R5 viruses replicated as efficiently as X4 viruses in the permissive clone when neutralizing anti-beta chemokine antibodies were added. Non-permissive cells blocked a post-entry step of the virus life-cycle and expressed early but not late HIV transcripts. Neutralizing anti-beta chemokine antibodies promoted R5 virus replication marginally in the non-permissive clone.
Some blood memory CD4 T cells retard R5 HIV-1 replication via endogenous beta-chemokines whereas others block productive R5 HIV-1 infection by an additional mechanism that interferes with a post-entry step of the virus life cycle. These natural barriers might contribute to lower pathogenicity of R5 HIV-1 strains for CD4 memory T cells than X4 viruses that emerge late in disease.
HIV-1毒株R5和X4可在体内感染CD4记忆T细胞。抗CD3/28刺激可诱导β趋化因子产生及CCR5下调,使这些细胞对R5 HIV-1感染产生抗性。在此,我们描述了一种额外的细胞机制,该机制可阻断CD4记忆T细胞的R5 HIV-1有效感染。
用原发性R5和X4 HIV-1毒株感染来源于血液的CD4记忆T细胞和CD4 T细胞克隆。病毒复制与CCR5表达及β趋化因子产生相关。分别通过PCR检测HIV逆转录早期和晚期产物来测定病毒进入和感染性。
R5毒株对CD4记忆T细胞的感染性比X4病毒低达1000倍。这种抗性与CCR5水平、Δ32突变以及CCR2-V64I/CCR5-59653T连锁突变无关。阻断内源性β趋化因子仅能轻微缓解这种限制。在单细胞水平,CD4记忆细胞对R5 HIV-1感染要么是允许的,要么是不允许的。即使在一个允许的克隆中,R5 HIV滴度也比X4病毒滴度低达10倍。然而,当加入中和性抗β趋化因子抗体时,R5病毒在允许的克隆中复制效率与X4病毒相同。不允许的细胞阻断了病毒生命周期的进入后步骤,并表达HIV早期转录本但不表达晚期转录本。中和性抗β趋化因子抗体在不允许的克隆中仅能轻微促进R5病毒复制。
一些血液记忆CD4 T细胞通过内源性β趋化因子延缓R5 HIV-1复制,而另一些细胞则通过一种额外机制阻断R5 HIV-1有效感染,该机制干扰病毒生命周期的进入后步骤。这些天然屏障可能导致R5 HIV-1毒株对CD4记忆T细胞的致病性低于疾病晚期出现的X4病毒。